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Abstract 
Background: One of the typical problems of cell savers is the retransfusion of the heparin added 
to the system. The aim of this study was to determine whether or not heparin, remaining in the 
prepared sample of retransfusion blood, might be responsible for disturbance in coagulation and 
increase in blood loss.  
 
Methods: Fifty patients undergoing coronary artery bypass grafting surgery (CABG) were 
randomly divided into two groups: group C (n=25) received cell-saver blood and group H (n=25) 
received homologous blood. Volumes of the intraoperative autologous and homologous 
transfusion, activated clotting time (ACT) of the transfused bloods, and ACT and amount of 
blood loss in the patients were measured intra and postoperatively.  
 
Results: There was no statistical difference between the groups in terms
 
of demographics, 
preoperative characteristics, or operative
 
details. Cell saver was used in 25 cases, and the average 
volume of blood autotransfused was 504± 158 mL. A significant statistical difference was 
observed in the mean volumes (460±200 vs. 80±160 mL; P = 0.0001) of perioperative allogeneic 
blood transfusions between groups H and C. Despite significant further cell-saver blood 
transfusion (504± 158 cc vs. 338±123 cc; P=0.001) and a significantly longer ACT of cell-saver 
blood than homologous blood (959±85 sec vs. 478±58 sec; P =0.0001) intraoperatively, there 
was no significant difference between the two groups in terms of postoperative blood loss (510 ± 
270 cc in group H vs. 454 ± 150 cc in group C;   P =0.362). 
 
Conclusion: Utilization of a cell saver was safe, with no increased risk of bleeding despite 
heparin added to the system. (Iranian Heart Journal 2012; 13(2):24-34). 
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Introduction 
leeding is the primary complication of 
cardiac surgery requiring cardiopulmonary 
bypass (CPB). In fact, 15% to 20% of the 
blood product use in the United States is 
associated with cardiac surgery.
[1-3] 
There are 
many investigations and articles that show the 
association between transfusion and increased 
rates of hospital mortality,
[4,5]
 perioperative 
infection and sepsis,
[ 6,7]
 pulmonary dysfunction, 
prolonged mechanical ventilation,
[8]
 and renal 
dysfunction,
[5,9,10,11]
 as well as persistent 
reduction in quality of life and death after 
surgery.
[12-16]  
For these reasons and  as a result 
of the growing concern over the increasing use 
of blood and its components during surgical 
procedures requiring CPB, The National 
Institutes of Health in 1973 recommended 
increased use of autologous blood 
transfusions.
[17]
  
A method suggested for handling blood and 
fluid in the surgical field is the cell salvage and 
washing system, which is thought to improve 
patient outcomes by removing debris from shed 
blood and thus decreasing the risk of stroke or 
neurocognitive dysfunction. In coronary
 
artery 
bypass grafting surgery (CABG), intraoperative 
cell salvage is the optimal
 
mechanical method 
for reducing the perioperative transfusion of
 
allogeneic red blood cells.
[18,19]
 This procedure is 
considered safe.
[20]
 But it is unknown whether 
the re-infusion of the salvaged blood affects the 
postoperative blood loss in patients. Although all 
cell savers adequately remove heparin from 
retransfused blood, previous studies have 
demonstrated that small amounts of heparin 
might remain in the prepared retransfused blood 
during intraoperative autotransfusion.
 [21,22]
 Our 
hypothesis was that heparin remaining in the 
prepared sample of retransfusion blood might be 
responsible for postoperative bleeding in 
comparison with transfusion of homologous 
blood.
 
We studied to what extent heparin is 
washed out during the preparation of 
retransfusion blood, when it is used as an 
anticoagulant for the autotransfusion cell-saver 
(Dideco) through the measurement of activated 
clotting time (ACT). There are no adequately 
powered studies in the literature comparing
 
postoperative blood loss when autologous or 
homologous blood is used.
  
Methods 
The study was designed as a randomized 
clinical trial and was performed at Shaheed 
Rajaei Cardiovascular, Medical and Research 
Center, Tehran University of Medical Sciences, 
Tehran, Iran. After the Research Ethics 
Committee's approval, 50 patients underwent 
primary, elective, isolated on-pump CABG 
surgery and met the criteria for inclusion in this 
study.  
Two groups were identified based on the use 
of packed red blood cell (homologous blood) as 
group H (n=25) or cell-saver blood (autologous 
blood) as group C (n=25). Intraoperative cell 
salvage of shed blood was
 
used in all the 
patients of group C, from skin incision to the 
closure of the
 
sternum at the completion of 
surgery. The inclusion criteria were as follows: 
primary, elective, on-pump CABG surgery; age 
between 30 and 70 years; left ventricular 
ejection fraction ≥45%, pump time <2 hours; 
and aortic clumping time <45 minutes. The 
exclusion criteria were: patients with known 
coagulation disorders; redo or emergency 
surgery; patients on Warfarin, heparin, or other 
systemic anticoagulant
 
drugs and antiplatelet 
drugs such as Aspirin (the patients either did not 
take Aspirin or took a maximum dose of 80 
mg/day) preoperatively; and co-existing 
diseases (renal and hepatic disease diabetes 
mellitus, hypertension, and endocrine and 
hematology disorders).BBBBBBBBBBBBBB
B 
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   All the patients received standard crystalloid 
maintenance volumes as well as standard 
anesthesia and perioperative
 
care and were 
operated
 
on by the same surgeon. The 
induction of anesthesia with standard doses of 
Etomidate, Sufentanil, and Cisatracurium and 
the maintenance of anesthesia with continuous 
infusion of Midazolam, Sufentanil, and 
Atracurium were done. Prior to skin incision, 
the cell-saver device was started in the 
automatic mode using 1000 ml saline as a 
washing solution.  ACT of the patient was 
obtained and recorded preoperatively as 
baseline or pre-heparin ACT (ACT before 
heparin administration). Before cannulation, 
bovine lung heparin 300 IU/kg was 
administered to achieve an ACT ≥ 480 sec. If 
this ACT was not achieved, the patient was 
excluded from the study. Since the heparin 
dose has a significant influence on the heparin 
concentration in the retransfusion blood,
 
the 
CPB-circuit, priming fluid (500 ml 
Hydroxyethyl starch 10% and 1000 ml 
lactated Ringer’ solution), the myocardial 
protection method (cold blood cardioplegia), 
and surgical techniques (by one surgeon) were 
uniform in all the patients. Cardiopulmonary 
bypass flow was 2.4 liter/ min/
 
m
2
.  
While the patient was on CPB, the trigger 
for the transfusion of allogeneic
 
red blood cells 
was a hemoglobin concentration of <7 g/dL 
(hematocrit (HCT) <21%), the patients were 
cooled to 32°C, and the mean
 
arterial pressure 
was maintained between 50 and 80 mm Hg 
with
 
the use of Phenylephrine or nitroglycerin. 
After re-warming and completion of
 
the 
aspects of surgery requiring CPB, blood 
samples were collected from the oxygenator 
and from autologous blood following 
concentration and washing with saline solution 
in the cell saver in group C or from the 
homologous blood in group H to measure 
ACT. Then the patients were weaned from
 
the 
CPB machine. After the termination of CPB, 
heparin was neutralized
 
using Protamine in a 
1:1 ratio. In group C, the blood aspirated from 
the wound area and the operative field as well 
as the blood within the CPB circuit
 
and the 
residual blood from the heart-lung machine 
was collected in the cell-saver reservoir, which 
was primed with 150 ml of normal saline with 
30,000 IU heparin/L added, washed, and 
concentrated with a continuous-flow cell saver 
before retransfusion.  The ACT of the blood 
collected in the cell-saver bag and bank blood 
before transfusion was checked.
 
The trigger 
for the transfusion of packed red
 
blood cells in 
group H after CPB was a hemoglobin 
concentration <8.0
 
g /dL (HCT <24%). The 
following time point for ACT measurement 
was employed 10 minutes after Protamine 
reversal and the transfusion of packed red 
blood cells in group H or the retransfusion of 
cell-saver blood in group C. Reinfusion of 
cell-saver blood regardless of post-CPB HCT 
was done. Postoperative blood loss was 
immediately measured after weaning of the 
patients from CPB and in the Intensive Care 
Unit (ICU) at the first, second, and third 8 
hours and all the 24 hours after surgery. 
Postoperatively, the only identifying
 
marks 
of the two groups were the patient's name and 
study identification. All the study 
investigators, patients, surgeon,
 
anesthetist, 
and persons involved in the patient's 
intraoperative
 
care were blinded to the amount 
of bleeding and treatment allocation in the 
ICUs. The persons involved in the patient’s 
postoperative care were blinded to the use of 
homologous or autologous blood for the 
patients. Because of the importance of 
hemodynamic stability, and specifically the 
effectiveness of blood pressure and blood 
volume on blood loss, the mean arterial 
pressure (MAP) and central venous pressure 
(CVP) were measured and recorded before, 
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during, and after surgery and at the first, 
second, and third 8 postoperative hours. The 
study population's demographics (age, sex, 
and weight), cardiac variables (ejection 
fraction), intraoperative hemodynamic 
variables (MAP and CVP), and CPB status 
(aortic cross-clamping time and CPB time) 
were recorded. 
The data are described as mean ±standard 
deviation for the interval and count (%) for the 
categorical variables. A one-sample 
Kolmogorov-Smirnov test was used to 
examine the fitness of interval variables to 
normal distribution. The associations between 
the type of transfusion and the other variables, 
including the patients` background, study 
outcomes, and other possible determinants, 
were investigated using the Student t-test for 
the interval data, the Pearson chi square for the 
nominal data, and the Mann-Whitney U test 
for the ordinal variables. The follow-up data 
were analyzed via the repeated measure 
analysis of variance (ANOVA) models. A p 
value <0.05 was considered statistically 
significant. The statistical analyses were 
performed with SPSS
®
 15 for Windows
®
 
(SPSS Inc., Chicago, Illinois).     
  
Results 
  Fifty patients undergoing on-pump 
CABG surgery were divided into two groups 
as was described earlier. Comparison of the 
values between the two groups was 
performed. The values were considered 
significant with a p value <0.05. There were 
no significant differences
 
between the 
groups in the listed variables, including the 
demographic, cardiac variables, and CPB 
status (Table 1).  
Comparison of the perioperative 
hemodynamic parameters, including MAP 
and CVP, between the two groups 
demonstrated statistically significant 
differences only in the baseline MAP of the 
patients and not in the other stages (Figures 
1 and 2). 
Comparison of the group receiving 
only homologous blood (group H) with the 
group receiving only autologous blood 
(group C) during the perioperative periods 
revealed that the use of the cell saver 
resulted in less requirement to packed red 
blood cells transfusion (460±200 mL in 
group H vs. 80±160 mL in group C; P = 
0.0001) and thus fewer subsequent donor 
exposures. Based on our hypothesis about 
the effects of residual heparin in the cell-
saver system on postoperative bleeding and 
its verification by ACT measurement at 
different times, we found no significant 
differences between the ACT of the samples 
drawn from the patients. Nevertheless, there 
were statistically significant differences 
between the ACT of the samples drawn from 
packed red blood cell bags and cell-saver 
blood bags (478±58 vs. 910±72; P =0.0001). 
Despite the high ACT of the prepared cell-
saver blood (910±72), there was no 
statistically significant difference between 
the ACT of the two groups measured and 
recorded at 10 minutes after Protamine 
reversal and transfusion of blood  post CPB 
(119±18 vs. 129±19; P =0.058 ) (Figure 3 
and Table 2).  
In our study, the mean volume of 
autologous blood transfusion 
intraoperatively was 504±158 mL, which 
could not induce bleeding more than the 
intraoperative transfusion of homologous 
blood with a mean volume of 338 ±
 
123 mL 
in the ICU at the first, second, and third 8 
postoperative hours and all the 24 
postoperative hours (Table 3).                                                                                                                                  
Intraoperatively, the mean volume of 
blood transfused in the two groups was 338 
±
 
123 mL, parallel with 4.8 ± 2 cc/kg in 
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group H vs. 504 ±158 mL, parallel with 7 ± 
2 cc/kg in group C; P =0.0001, while the 
mean volume of blood loss in the first 24 
hours following surgery in the groups was 
510± 270 ml in group H vs. 454± 150 ml in 
group C; P =0.362. These data demonstrated 
that despite significant differences between 
the
 
groups in terms of the amount of 
intraoperative blood received, there were no 
statistically significant differences with 
respect to postoperative blood loss. 
Autotransfusion did not produce any 
significant blood loss
 
when compared with 
homologous blood transfusion
 
(P =0.512, 
ANOVA). 
 
  
Fifteen  patients in the two groups 
received transfusion of allogeneic red blood 
cells postoperatively, but the total of the 
packed cell units transfused in group H was 
higher than that in group C (16 units vs. 11 
units). Seven patients from group C and 8 
patients from group H required packed red 
blood cells postoperatively (8/25, group H 
vs. 7/25, group C). There was reduced 
requirement for homologous blood products 
during the first 24 hours following surgery 
when a cell-saver apparatus was employed 
intraoperatively (16 units totally or an 
average of 0.7± 1 units in group H vs. 11 
units totally or an average of 0.4± 0.8 units 
in group C); however, there was no 
statistically significant difference between 
the two groups (P =0. 429). No patient was 
explored for excessive bleeding, and all the 
patients
 
survived to discharge. 
 
 
 
 
Table1: Demographic and cardiac variables and  
cardiopulmonary bypass status  
 
CPB= cardiopulmonary bypass         
 LVEF= left ventricular ejection fraction 
 
Table 2 : Intraoperative Activated Clotting Time 
measurement 
ACT (sec) Group H Ggroup C p value 
Baseline (pre heparin) 152±33 151±30 0.979 
2 minutes post heparin 633±150 582±127 0.200 
5 minutes  pre-CPB  
weaning 
573±114 556±101 0.595 
ACT of  bloods 
(C&H) 
478±370 959±85 0.000 
10minutes  post 
transfusion 
119±18 129±19 0.058 
Note: ACT= Activated Clotting Time       CPB=Cardiopulmonary 
Bypass 
 5 minutes pre-CPB weaning means: ACT measurement 5 min before 
weaning of CPB.  
 ACT of bloods means: ACT of salvaged blood and homologous blood 
before transfusion. 
10 minutes post- transfusion means: ACT measurement 10 min after 
Protamine reversal and transfusion of autologous and homologous 
blood. 
Table 3 : Postoperative blood loss 
Blood Loss (mL/kg) 
Blood Loss (mL) group H group C p value 
First 8 hours post-op 
3.3 ± 2.5 
242 ± 184 
3.0 ± 1.6 
210 ± 103 
0.635 
0.463 
Second 8 hours post-op 
2.2 ± 2 
156 ± 127 
1.6 ± 1.0 
112 ± 76 
0.127 
0.144 
Third 8 hours post-op 
1.4 ± 1.5 
105 ± 105 
1.8 ± 1.0 
131 ± 79 
0.288 
0.333 
Total 24 hours post-op 
7.0 ± 3.7 
510 ± 270 
6.4 ± 2.2 
454 ± 150 
0.512 
0.362 
 
 
 
 
 
 Group H Group C p value 
Sex (M/F) 16/9 17/8 0.107 
Age (yr) 58±5.4 55±14 0.239 
Weight (kg) 
72±7 74±6 0.820 
CPB time 
(min) 
73±19 69±17 0.491 
Clamp time 
(min) 
38±15 32±10 0.128 
LVEF (%) 48±4.8 48±4.5 0.881 
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Figure 1: Perioperative Mean Arterial Pressure 
MAP= Mean Arterial Pressure        
CPB=Cardiopulmonary Bypass       Op=Operation 
 
 
 
 
 
 
 
 
 
Figure 2: Perioperative Central Venous Pressure 
CVP= central venous pressure         CPB=Cardiopulmonary Bypass       Op=Operation 
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Figure 3: Intraoperative Activated Clotting Time measurement 
 
 
 
Discussion 
The causes of bleeding in cardiac 
surgery are surgical damage
 
to blood vessels 
and the development of coagulopathy 
resulting
 
from a combination of an acquired 
defect in platelet function,
 
inappropriate 
fibrinolysis, and a reduction in circulating 
coagulation
 
factors.
[22 -24]
 Some of these 
causes relate to the aspects of perioperative 
care. Various methods to reduce blood 
consumption are used in cardiac surgery, 
including mechanical and pharmacological 
techniques. 
[ 25]
  These methods may 
maintain a patient's HCT, reduce the need 
for homologous blood transfusion, reduce 
the development
 
of coagulopathy, and 
perhaps reduce intraoperative and  
postoperative
 
blood loss, but based 
on the results of a meta-analysis in 2009, the 
use of a cell saver has no effect on hospital 
mortality, postoperative stroke or transient  
 
 
 
ischemia attack, atrial fibrillation, 
renal dysfunction, infection, patients 
requiring fresh frozen plasma, and patients 
requiring platelet transfusions.
[26]
 The 
optimal methods in CABG is the 
intraoperative use of a cell saver. Disorders 
in blood coagulation and RBC function 
during the use of mechanical cell salvage 
and autotransfusion have been reported in 
previous and recent studies.
 [27-29]
 On the 
other hand, there are studies that confirm the 
safety and efficiency of perioperative cell 
salvage and autotransfusion after CABG. 
[21]
 
The present study was performed to verify 
whether or not heparin, remaining in the 
prepared sample of retransfusion blood, 
might be responsible for postoperative blood 
loss. 99999999999999999999999999999
 
This prospective randomized control 
trial compared the amount of postoperative  
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bleeding after the retransfusion of cell-saver 
blood with homologous blood in patients 
undergoing on-pump CABG. The results 
demonstrated that in comparison with the 
transfusion of packed red blood cells, the 
reinfusion of cell-saver blood was not 
responsible for postoperative blood loss and 
autotransfusion was a safe and effective 
method for reducing the
 
use of homologous 
bank blood after first-time CABG. These 
results are consistent with the findings of 
Gavin J. Murphy and his colleagues in 
2004.
[21]
  
All cell savers adequately remove 
heparin from retransfused blood. Be that as 
it may, there is concern that cell-saver 
suction may cause increased fragmentation
 
of erythrocytes and removal of platelets 
[26-
29] 
and so it may cause postoperative blood 
loss. Reents et al. found increased levels of 
free hemoglobin
 
and fewer platelets with 
cell-saver suction compared with cardiotomy
 
suction.
 [30]
 On the other hand, the 
mechanical cell salvage procedure affects 
the RBC function in patients undergoing 
cardiac surgery with CPB. Disorders in 
blood coagulation during the use of 
autotransfusion have been reported in 
previous studies.
 [28,29] Investigation of 
heparin management during cardiac surgery 
by Boldt et al. through comparison of six 
various blood-conservation techniques 
demonstrated that fibrinogen concentration 
and antithrombin-III levels were lower in the 
cell-saver group but they were not decreased 
critically during the entire investigation 
period. 
[31]   
In another study, Andrew A. 
Klein et al. found that patients in the cell-
salvage group had a lower platelet
 
count and 
fibrinogen level one hour postoperatively, 
but there was
 
no difference in postoperative 
bleeding between the two groups
. [32] 
That is 
consistent with our finding. According to our 
results, the patients showed no irregular 
heparin load and abnormal ACT following 
the transfusion of autologous blood with 
high ACT levels. As a result, the use of the 
cell saver is not associated with an increased 
risk of bleeding. We found no difference 
between the two groups
 
regarding 
postoperative blood loss
 
requirement for re-
exploration for bleeding, but there was need 
for packed red blood cell transfusions in 
some of the patients in the two groups.
 
Our results demonstrated that the use 
of cell salvage in patients undergoing
 
elective first-time cardiac surgery could 
reduce the number
 
of patients exposed to 
allogeneic blood transfusion. When 
considering
 
only patients not requiring 
reoperation for postoperative bleeding,
 
we 
did find a reduction in the number of the 
units of allogeneic
 
blood transfused in the 
cell-salvage group compared with the 
homologous group.  
 
Conclusion 
This prospective study demonstrated 
that intraoperative salvaging of blood during 
cardiac surgery utilizing the Dideco cell-
saver device did not increase the risk of 
postoperative bleeding and did not impose 
any additional requirement for homologous 
blood products. 
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